← Back to Clinical Trials
Recruiting NCT05616416

NCT05616416 International Big Data Centre in Emergency Medicine

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05616416
Status Recruiting
Phase —
Sponsor Guangdong Provincial People's Hospital
Condition Emergency Medicine
Study Type OBSERVATIONAL
Enrollment 500,000 participants
Start Date 2011-01-01
Primary Completion 2027-12

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 500,000 participants in total. It began in 2011-01-01 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational study aims to use electronic health records to build an International Big Data Centre in Emergency Medicine, within the Institute of Sciences in Emergency Medicine (ISEM) at the Guangdong Provincial People's Hospital. The main questions it seeks to answer are not limited to the following: * Identify the relationship between Emergency Department Length of Stay (EDLOS), Mortality, and Adverse Events (AE) * Identify the risk factors associated with high mortality and AE rate among patients who experience prolonged EDLOS * Other research questions related to emergency medicine, such as building prediction and cluster models for acute diseases

Eligibility Criteria

Inclusion Criteria: * Every patient who ever visited Emergency Department from 2011-2022 Exclusion Criteria: * Patients with missing demographic (age, gender, etc.) and triage data

Contact & Investigator

Central Contact

Abdelouahab Bellou, MD, PhD, MSc

✉ abellou402@gmail.com

📞 +16176693707

Principal Investigator

Abdelouahab Bellou, MD, PhD, MSc

PRINCIPAL INVESTIGATOR

Guangdong Provincial People's Hospital

Frequently Asked Questions

Who can join the NCT05616416 clinical trial?

This trial is open to participants of all sexes, studying Emergency Medicine. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05616416 currently recruiting?

Yes, NCT05616416 is actively recruiting participants. Contact the research team at abellou402@gmail.com for enrollment information.

Where is the NCT05616416 trial being conducted?

This trial is being conducted at Guangzhou, China.

Who is sponsoring the NCT05616416 clinical trial?

NCT05616416 is sponsored by Guangdong Provincial People's Hospital. The principal investigator is Abdelouahab Bellou, MD, PhD, MSc at Guangdong Provincial People's Hospital. The trial plans to enroll 500,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology